Combining Artesunate-Amodiaquine and Ciprofloxacin Improves Serum Lipid Profile of Mice Exposed to Plasmodium Berghei Berghei
DOI:
https://doi.org/10.7439/ijbr.v5i8.683Abstract
We investigated the effects of combining artesunate-amodiaquine and ciprofloxacin on the serum lipid profile of mice exposed to Plasmodium berghei berghei . The use of this combination for the treatment of febrile illness, suspected malaria and malaria-typhoid coinfection is very common in Nigeria. 60 adult mice and Plasmodium berghei berghei were used in this study. Calculated amount of the drugs was administered orally based on dosages of 4mg/kg body weight of Artesunate, 10mg/kg body weight of amodiaquine and 9mg/Kg body weight of ciprofloxacin. The drugs were administered in two divided doses for 3 and 5 days for ACT and ciprofloxacin respectively. The result of our study showed that treatment with the combination of ACT and ciprofloxacin improved serum TG levels better than groups treated with either ACT or ciprofloxacin alone. There were significant (p 0.05) increases in the HDL-chol and insignificant (p>0.05) changes in VLDL-chol and LDL-chol of groups treated with ACT and ciprofloxacin only in comparison with the normal control. Animals treated with ACT plus ciprofloxacin showed insignificant (p>0.05) increases in all fractions of cholesterol tested in comparison to the normal control. All parameters in treated groups tested showed significant increases when compared to the parasitized untreated animals. The result of our study showed that the use of this triple regimen in management of malaria restored the lipid profile deranged by the disease better than either ACT or ciprofloxacin alone. Although synergism in the drugs action may be considered, the actual mechanism is a matter of further research.Downloads
Download data is not yet available.
Downloads
Published
2014-08-30
Issue
Section
Original Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.
How to Cite
1.
Combining Artesunate-Amodiaquine and Ciprofloxacin Improves Serum Lipid Profile of Mice Exposed to Plasmodium Berghei Berghei. Int Jour of Biomed Res [Internet]. 2014 Aug. 30 [cited 2026 Mar. 29];5(8):487-9. Available from: https://ssjournals.co.in/index.php/ijbr/article/view/1049